Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Protagonist: Crohn's disease recurrence can be prevented after ileal resection.

Literature DB >> 12117870

Protagonist: Crohn's disease recurrence can be prevented after ileal resection.

P Rutgeerts¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2002 PMID： 12117870 PMCID： PMC1773309 DOI： 10.1136/gut.51.2.152

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

8 in total

1. Predictability of the postoperative course of Crohn's disease.

Authors: P Rutgeerts; K Geboes; G Vantrappen; J Beyls; R Kerremans; M Hiele
Journal: Gastroenterology Date: 1990-10 Impact factor: 22.682

2. Operative and environmental risk factors for recurrence of Crohn's disease.

Authors: D Moskovitz; R S McLeod; G R Greenberg; Z Cohen
Journal: Int J Colorectal Dis Date: 1999-11 Impact factor: 2.571

3. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.

Authors: H Lochs; M Mayer; W E Fleig; P B Mortensen; P Bauer; D Genser; W Petritsch; M Raithel; R Hoffmann; V Gross; M Plauth; M Staun; L B Nesje
Journal: Gastroenterology Date: 2000-02 Impact factor: 22.682

4. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.

Authors: P Rutgeerts; M Hiele; K Geboes; M Peeters; F Penninckx; R Aerts; R Kerremans
Journal: Gastroenterology Date: 1995-06 Impact factor: 22.682

5. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).

Authors: R Caprilli; A Andreoli; L Capurso; G Corrao; G D'Albasio; A Gioieni; G Assuero Lanfranchi; I Paladini; F Pallone; V Ponti
Journal: Aliment Pharmacol Ther Date: 1994-02 Impact factor: 8.171

6. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease.

Authors: R S McLeod; B G Wolff; A H Steinhart; P W Carryer; K O'Rourke; D F Andrews; J E Blair; J R Cangemi; Z Cohen; J B Cullen
Journal: Gastroenterology Date: 1995-08 Impact factor: 22.682

7. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group.

Authors: C Brignola; M Cottone; A Pera; S Ardizzone; M L Scribano; R De Franchis; A D'Arienzo; G D'Albasio; D Pennestri
Journal: Gastroenterology Date: 1995-02 Impact factor: 22.682

8. Risk factors for early postoperative recurrence of Crohn's disease.

Authors: E Lautenbach; J A Berlin; G R Lichtenstein
Journal: Gastroenterology Date: 1998-08 Impact factor: 22.682

8 in total

11 in total

1. Surgical predictors of recurrence of Crohn's disease after ileocolonic resection.

Authors: Marco Scarpa; Cesare Ruffolo; Eugenia Bertin; Lino Polese; Teresa Filosa; Daniela Prando; Duilio Pagano; Lorenzo Norberto; Mauro Frego; Davide F D'Amico; Imerio Angriman
Journal: Int J Colorectal Dis Date: 2007-05-30 Impact factor: 2.571

2. High Incidence of Recurrent Crohn's Disease Following Colectomy for Ulcerative Colitis Revealed with Long Follow-Up.

Authors: Steven Shamah; Judy Schneider; Burton I Korelitz
Journal: Dig Dis Sci Date: 2017-12-28 Impact factor: 3.199

3. Does microscopic involvement of the surgical margins after ileocecectomy in Crohn's patients predict early recurrence?

Authors: Meir Zemel; Elian Solo; Hagit Tulchinsky
Journal: Int J Colorectal Dis Date: 2021-04-29 Impact factor: 2.571

4. A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's disease.

Authors: Adjoa Anyane-Yeboa; Akihiro Yamada; Haider Haider; Yunwei Wang; Yuga Komaki; Fukiko Komaki; Joel Pekow; Sushila Dalal; Russell D Cohen; Lisa Cannon; Konstantin Umanskiy; Radhika Smith; Roger Hurst; Neil Hyman; David T Rubin; Atsushi Sakuraba
Journal: Aliment Pharmacol Ther Date: 2018-08-20 Impact factor: 8.171

Protagonist: Crohn's disease recurrence can be prevented after ileal resection.

1. Predictability of the postoperative course of Crohn's disease.

2. Operative and environmental risk factors for recurrence of Crohn's disease.

3. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.

4. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.

5. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).

6. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease.

7. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group.

8. Risk factors for early postoperative recurrence of Crohn's disease.

1. Surgical predictors of recurrence of Crohn's disease after ileocolonic resection.

2. High Incidence of Recurrent Crohn's Disease Following Colectomy for Ulcerative Colitis Revealed with Long Follow-Up.

3. Does microscopic involvement of the surgical margins after ileocecectomy in Crohn's patients predict early recurrence?

4. A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's disease.

Review 5. Postoperative Crohn's disease recurrence: a practical approach.

6. Interventions for maintenance of surgically induced remission in Crohn's disease: a network meta-analysis.

7. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.

8. Salvianolic Acid B Restored Impaired Barrier Function via Downregulation of MLCK by microRNA-1 in Rat Colitis Model.

9. Characterization of Crohn's disease patients in Egypt: Risk factors for postoperative recurrence (A cohort study).

10. Rare and Serious Adverse Effects of Anti-Tumor Necrosis Factor-Alpha (TNF-α) Agents in Crohn's Disease.